Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $275.1M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $981.0K in total
- 7
- 13F holdersQ2 2026, +19 vs. previous quarter
- 126
- 13F valueReported value at the end of Q2 2026
- $275.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ABEO, Q2 2026
No superinvestor reported holding ABEO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Abeona Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)5:48 PM ET | Sep 1 | Same day | Alvino MarkDirector | SSale | −15.0K | $5.86 | −$88.0K | −19.5%62.1K after | |
| Jul 22, 2026 (view filing)4:30 PM ET | Jul 21 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −1.48K | $6.53 | −$9.65K | −0.3%492.1K after | |
| Jul 9, 2026 (view filing)7:24 PM ET | Jul 9 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −24.9K | $6.96 | −$173.3K | −4.8%493.6K after | |
| Jul 9, 2026 (view filing)7:22 PM ET | Jul 9 | Same day | Seshadri VishwasChief Executive Officer | SSale | −68.0K | $6.96 | −$473.3K | −4.9%1.31M after | |
| Jul 9, 2026 (view filing)7:20 PM ET | Jul 9 | Same day | O'Malley Brendan M.SVP, Chief Legal Officer | SSale | −12.1K | $6.96 | −$83.9K | −2.7%428.0K after | |
| Jul 9, 2026 (view filing)7:17 PM ET | Jul 9 | Same day | Vasanthavada MadhavChief Commercial Officer | SSale | −12.6K | $6.96 | −$87.8K | −4.2%290.6K after | |
| Jul 2, 2026 (view filing)4:30 PM ET | Jun 30 | 2 days | Alland LeilaDirector | SSale | −11.0K | $5.92 | −$65.1K | −6.3%162.6K after | |
| Jun 15, 2026 (view filing) | Jun 15 | Same day | Silverstein Christine BerniDirector | SSale | −18.2K | $5.71 | −$103.7K | −13.2%119.6K after | |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −49.3K | $5.37 | −$265.1K | −8.7%518.4K after | 3 lots10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8-9 | 1 day | Vasanthavada MadhavChief Commercial Officer | SSale | −9.62K | $5.36 | −$51.5K | −3.1%303.5K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Abeona Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10,272,980 | $63.5M | 1.92% | +5,259,928+104.9% | Added |
| BlackRock, Inc. | 3,352,474 | $20.7M | 0.00% | +156,944+4.9% | Added |
| Cable Car Capital LLC | 3,007,329 | $18.6M | 0.40% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 2,987,000 | $18.5M | 1.67% | −113,000−3.6% | Reduced |
| Vanguard Capital Management LLC | 2,211,433 | $13.7M | 0.00% | +46,582+2.2% | Added |
| Resources Investment Advisors, LLC. | 1,653,024 | $10.2M | 0.09% | +1,653,024 | New |
| AWM Investment Company, Inc. | 1,486,130 | $9.18M | 0.80% | +683,000+85.0% | Added |
| Geode Capital Management, LLC | 1,261,090 | $7.80M | 0.00% | +51,293+4.2% | Added |
| Kennedy Capital Management, Inc. | 1,240,071 | $7.66M | 0.14% | −23,440−1.9% | Reduced |
| Goldman Sachs Group Inc | 1,224,806 | $7.57M | 0.00% | +94,187+8.3% | Added |